DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers
- PMID: 24698998
- PMCID: PMC3974638
- DOI: 10.1371/journal.pgen.1004256
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers
Abstract
Single Nucleotide Polymorphisms (SNPs) in genes involved in the DNA Base Excision Repair (BER) pathway could be associated with cancer risk in carriers of mutations in the high-penetrance susceptibility genes BRCA1 and BRCA2, given the relation of synthetic lethality that exists between one of the components of the BER pathway, PARP1 (poly ADP ribose polymerase), and both BRCA1 and BRCA2. In the present study, we have performed a comprehensive analysis of 18 genes involved in BER using a tagging SNP approach in a large series of BRCA1 and BRCA2 mutation carriers. 144 SNPs were analyzed in a two stage study involving 23,463 carriers from the CIMBA consortium (the Consortium of Investigators of Modifiers of BRCA1 and BRCA2). Eleven SNPs showed evidence of association with breast and/or ovarian cancer at p<0.05 in the combined analysis. Four of the five genes for which strongest evidence of association was observed were DNA glycosylases. The strongest evidence was for rs1466785 in the NEIL2 (endonuclease VIII-like 2) gene (HR: 1.09, 95% CI (1.03-1.16), p = 2.7 × 10(-3)) for association with breast cancer risk in BRCA2 mutation carriers, and rs2304277 in the OGG1 (8-guanine DNA glycosylase) gene, with ovarian cancer risk in BRCA1 mutation carriers (HR: 1.12 95%CI: 1.03-1.21, p = 4.8 × 10(-3)). DNA glycosylases involved in the first steps of the BER pathway may be associated with cancer risk in BRCA1/2 mutation carriers and should be more comprehensively studied.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Milne RL, Osorio A, Cajal TR, Vega A, Llort G, et al.. (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14: 2861–2869. - PubMed
-
- Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, et al.. (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9: 104. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 17528/CRUK_/Cancer Research UK/United Kingdom
- 11174/CRUK_/Cancer Research UK/United Kingdom
- P30 CA076292/CA/NCI NIH HHS/United States
- U19 CA148537/CA/NCI NIH HHS/United States
- U10 CA037517/CA/NCI NIH HHS/United States
- CA 37517/CA/NCI NIH HHS/United States
- 1 U19 CA 148537/CA/NCI NIH HHS/United States
- U10 CA180868/CA/NCI NIH HHS/United States
- UL1 TR000430/TR/NCATS NIH HHS/United States
- CA116201/CA/NCI NIH HHS/United States
- UG1 CA189867/CA/NCI NIH HHS/United States
- R01 CA140323/CA/NCI NIH HHS/United States
- R01CA140323/CA/NCI NIH HHS/United States
- CA128978/CA/NCI NIH HHS/United States
- RC4 CA153828/CA/NCI NIH HHS/United States
- U10 CA101165/CA/NCI NIH HHS/United States
- R01 CA142996/CA/NCI NIH HHS/United States
- P50 CA125183/CA/NCI NIH HHS/United States
- UM1 CA164920/CA/NCI NIH HHS/United States
- P30 CA168524/CA/NCI NIH HHS/United States
- U01 CA161032/CA/NCI NIH HHS/United States
- CA125183/CA/NCI NIH HHS/United States
- 11022/CRUK_/Cancer Research UK/United Kingdom
- N02-CP-11019-50/CP/NCI NIH HHS/United States
- C12292/A11174/CRUK_/Cancer Research UK/United Kingdom
- CA 27469/CA/NCI NIH HHS/United States
- U10 CA027469/CA/NCI NIH HHS/United States
- R01 CA128978/CA/NCI NIH HHS/United States
- N02 CP011019/CP/NCI NIH HHS/United States
- N02 CP065504/CP/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- R01CA74415/CA/NCI NIH HHS/United States
- CA 101165/CA/NCI NIH HHS/United States
- U01 CA113916/CA/NCI NIH HHS/United States
- RC4A153828/RC/CCR NIH HHS/United States
- 15007/CRUK_/Cancer Research UK/United Kingdom
- P30 CA033752/CA/NCI NIH HHS/United States
- 17523/CRUK_/Cancer Research UK/United Kingdom
- 16563/CRUK_/Cancer Research UK/United Kingdom
- 5U01CA113916/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- 1U01CA161032/CA/NCI NIH HHS/United States
- P30 CA016520/CA/NCI NIH HHS/United States
- N02-CP-65504/CP/NCI NIH HHS/United States
- C1287/A11990/CRUK_/Cancer Research UK/United Kingdom
- R01 CA074415/CA/NCI NIH HHS/United States
- 10118/CRUK_/Cancer Research UK/United Kingdom
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- U10 CA180822/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
